Timing of sudden death relative to the hemodialysis procedure: Commentary

Nature Clinical Practice Nephrology

Volumn 2, Issue 12, 2006, Pages 668-669

  Perl, Jeffrey ^a   Chan, Christopher T ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; POTASSIUM;

ADULT; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DEATH; DEATH CERTIFICATE; DIABETES MELLITUS; DISEASE COURSE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORBIDITY; NOTE; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; POTASSIUM BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SCREENING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; SYMPTOM; TIME OF DEATH; UNITED STATES; WITNESS;

EID: 33845254577     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0345     Document Type: Note

References (5)

1. Kundhal K et al. (2005) Newer paradigms in renal replacement therapy: will they alter cardiovascular outcomes? Cardiol Clin 23: 385-391
2. Amann K et al. (1994) A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4: 1814-1819
3. Hausberg M et al. (2002) Sympathetic nerve activity in end-stage renal disease. Circulation 106: 1974-1979
4. Herzog CA et al. (2005) Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68: 818-825
5. Saran R et al. (2006) Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228